Alterations in circulating vasoactive substances in the critically ill —a comparison between survivors and non-survivors
Regulation of circulatory homeostasis is based on several factors including various circulating vasoactive substances. Whether these regulators differ between survivors and non-survivors was investigated in critically ill patients.
Clinical investigation on a surgical intensive care unit of an university hospital.
60 consecutive patients suffering from trauma (n=21) or postoperative complications (n=39) were studied prospectively. The patients were divided into survivors (n=27) and non-survivors (n=33). Therapy was adjusted to the standards of modern intensive care management by physicians who were not involved in the study.
Measurements and results
Endothelin-1, atrial natriuretic peptide (ANP), vasopressin, renin, and catecholamine (epinephrine, norepinephrine) plasma levels were measured from arterial blood samples using radioimmunoassay (RIA) or high-pressure liquid chromatography (HPLC) technique on the day of admission to ICU and during the following 5 days. Various hemodynamic parameters were also monitored during that period. The non-survivors showed elevated pulmonary artery pressure (PAP: 34.1±5.4 mmHg) and pulmonary capillary wedge pressure (PCWP: 20.3±7.3 mmHg) already at the beginning of the study. Cardiac index (CI) did not differ among the groups, whereas right ventricular ejection fraction (RVEF) decreased in the non-survivors. PaO2/FIO2 decreased only in the non-survivors, whereas VO2 increased in the survivors (from 246±48 to 331±43 ml/min). Plasma levels of renin (from 206±40 to 595±81 pg/ml) and vasopressin (from 5.78±0.82 to 7.97±0.69 pg/ml) increased significantly in the non-survivors. Epinephrine and norepinephrine plasma concentrations were elevated in the non-survivors already at baseline and tremendously increased in these patients during the following days. ANP plasma levels significantly increased also only in the non-survivors (from 188±63 to 339±55 pg/ml) (p<0.05). Endothelin-1 decreased in the survivors, whereas it significantly increased in the non-survivors (from 3.62±0.68 to 9.37±0.94 pg/ml) during the study period (p<0.05). Analyses of co-variance revealed overall no significant correlation between circulating vasoactive substances and hemodynamics.
Systemic and regional regulators of the circulation were markedly changed by critical illness. In survivors, these regulators almost normalized within the study period of 5 days, whereas in non-survivors these alterations were even aggravated. It can only be speculated whether these regulator systems were influenced by activation of various mediator systems or whether they themselves influenced the negative outcome in the non-survivors.
Key wordsCritical illness Hemodynamics Circulation Vasoactive substances Endothelin Catecholamines Atrial natriuretic peptide Outcome
Unable to display preview. Download preview PDF.
- 1.Rose BD (1984) Regulation of the effective circulating volume. Rose BD (ed) Clinical physiology of acid-base and electrolyte disorders. McGraw Hill, New York, pp 171–190Google Scholar
- 2.Kehlet H (1984) The stress response to anaesthesia and surgery: Release mechanisms and modifying factors. Anesth Clin North Am 2:315–339Google Scholar
- 4.Turnbull AV, Little RA (1993) Neurohormonal regulation after trauma. Circulating cytokines may also contribute to an activated sympathetic-adrenal control. In: Vincent JL (ed) Update in intensive care and emergency medicine. Springer, Berlin Heidelberg New York Tokyo, pp 574–581Google Scholar
- 8.Lüscher TF (1992) Endothelin: systemic arterial and pulmonary effects of a new peptide with biologic properties. Am Rev Respir Dis 146 [Suppl 2]:S 56-S 60Google Scholar
- 9.Rushkoaho H, Lang RE, Toth M, Ganten D, Unger T (1987) Release and regulation of atrial natriuretic peptide (ANP). Eur Heart J 8 (Suppl B):99–109Google Scholar
- 11.Underwood RD, Chan DP, Burnett JC (1991) Endothelin: an endothelium-derived vasoconstrictor peptide and its role in congestive heart failure. Heart Failure 4:50–58Google Scholar
- 13.Koller J, Mair P, Wiser C, Pomaroli A, Puschendorf B, Herold M (1991) Endothelin and big endothelin concentration in injured patients. N Engl J Med 21:1518Google Scholar
- 21.Thijs LG (1988) Transport and consumption of oxygen in septic shock. In: Vincent JL (ed) Update in intensive care and emergency medicine, vol. 5. Springer, Berlin Heidelberg New York Tokyo, pp 44–50Google Scholar
- 22.Takala J, Ruokonen E (1991) Blood flow and adrenergic drugs in septic shock. In: Vincent JL (ed) Update in intensive care and emergency medicine, vol 14. Springer, Berlin Heidelberg New York Tokyo, pp 144–152Google Scholar
- 26.Felicetta JV, Sowers JR (1987) Endocrine changes with critical illness. Crit Care Clin 5:855–869Google Scholar
- 29.Koyama H, Tabata T, Nishzawa Y, Inoue T, Morii H, Yamaji T (1989) Plasma endothelin levels in patients with uremia. Lancet I:991–992Google Scholar
- 30.Athanassopoulos G, Cokkino DV (1991) Atrial natriuretic factor. Prog Cardiovasc Dis 5:313–328Google Scholar
- 33.Goetz KL, Wang BC, Madwed JB, Zhu JI, Leadly RJ (1988) Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs. Am J Physiol 55:R 1064–8Google Scholar
- 34.Yanagisawa M, Kurihara H, Kimura S (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 322:411–415Google Scholar
- 36.Hartter E, Woloszczuk W (1989) Radioimmunoassay of endothelin. Lancet 1:909Google Scholar
- 40.Boarder MR, Marriott DB (1989) Characterization of endothelin-1 stimulation of catecholamine release from adrenal chromaffin cells. J Cardiovasc Pharmacol 13 [Suppl 5]:S 223–224Google Scholar